News related to Doxil (Doxorubicin) and/or conditions it is approved for
First-line Doxorubicin for Advanced Sarcoma, Not Combo? Source: Medscape Hematology-Oncology Headlines [2017.09.27] Doxorubicin should remain first-line therapy for patients with soft-tissue sarcoma, conclude trialists who compared it with a gemcitabine and docetaxel combination. Medscape Medical News